Financials

  • Market Capitalization 39.21 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.68
ratio cours/chiffre d'affaires
5 743.48

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
239
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
664.45 USD+1.27%+0.55%+8.01%+21.77%69.66 B USD
299
ARGX
argenx SE - American Depositary Shares
862.93 USD+0.41%-5.19%-3.10%+50.86%53.40 B USD
389
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
279.14 USD-0.75%-26.25%-0.77%-13.09%37.27 B USD
487
MRNA
Moderna, Inc. - Common Stock
68.28 USD+1.25%-7.48%+21.47%+112.12%27.09 B USD

Nouvelles